14 Aug
ATTR amyloidosis is caused by the accumulation of misfolded transthyretin protein in tissues. Learn the differences between wild-type and hereditary ATTR, important cardiac and neurological red flags, how ATTR is diagnosed, the role of genetic testing, and current treatment approaches.
READ MORE14 Aug
ATTR and AL amyloidosis can both affect the heart but arise from different precursor proteins and require different treatment. Learn the key differences in causes, red flags, diagnosis, testing and management.
READ MORE14 Aug
Cardiac amyloidosis is an important and often under-recognized cause of heart failure and increased ventricular wall thickness. Learn the key cardiac and extracardiac red flags, differences between ATTR-CM and AL-CM, and the modern diagnostic pathway using laboratory testing, echocardiography, CMR and bone scintigraphy.
READ MORE14 Aug
Amyloidosis is a group of diseases caused by abnormal amyloid protein deposits in tissues and organs. Learn about AL, ATTR and AA amyloidosis, their symptoms, diagnosis and treatment.
READ MORE4 Mar
Not all heart failure is the same. Learn why cardiac amyloidosis needs a different treatment approach and which drugs should be avoided.
READ MORE8 Sep
Amyloidosis awareness in Africa is improving, but many cases are still missed. Learn why early recognition is critical for saving lives.
READ MORE
We advance cardiac amyloidosis care across Africa through collaboration, training, and research. Join us to change the future of heart health and empower local clinicians with knowledge and tools.